Identifying gene mutations and specific markers prior to initiating therapy can result in better patient outcomes as well as substantial cost savings by avoiding poor drug choices and needless over prescribing.

Mutation Analysis Tests

ALK 2p23 rearrangement by FISH

ALK Anaplastic Lymphoma Kinase -1 by IHC

AML Mutation Analysis Panel

ATM/CEP11 deletion 11q22.3 by FISH

BCR/ABL1 t(9;22) by FISH

BRAF Mutation Analysis by Next Generation Sequencing

CEBPA Mutation Analysis*

EGFR Mutation Analysis by Next Generation Sequencing

FLT3 Mutation Analysis*

IgVH Somatic Hypermutation by Next Generation Sequencing

JAK2 V617F Mutation Analysis by PCR

KIT (D816V) Mutation*

KRAS Mutation Analysis by Next Generation Sequencing

MYD88 p.L265P Mutation Analysis by Next Generation Sequencing

Myeloid Extended Mutation Analysis Panel by Next Generation Sequencing